Floatz logo

Anakinra

Hypersecretion; Cortisol

University Hospital, Basel, Switzerlandprotein_peptidePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Hypersecretion; Cortisol cohort.

Asset / SponsorPhaseRating
Osilodrostat
Johns Hopkins University
Phase 4BBB
Metyrapone
Mayo Clinic
Phase 2CCC
DARATUMUMAB
M.D. Anderson Cancer Center
Phase 1CC
Edicotinib
M.D. Anderson Cancer Center
Phase 1C
Semaglutide
University of Texas Southwestern Medical Center
N/AD
Solu-Cortef
University of Minnesota
Phase 1NR

Same molecule, other indications

Anakinra is also rated in:

obesity disorderDormant
BB
Indicative ·
64 / 100
View asset →
hypogonadotropic hypogonadismDormant
BB
Indicative ·
64 / 100
View asset →
systemic-onset juvenile idiopathic arthritisDormant
B
Indicative ·
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →